... To ease and unify Rave End of Study (EOS) document management, Medidata (NASDAQ:MDSO) today introduced a new, automated function of Edge Regulatory Content Management ...
... II clinical and diagnostic image viewing solutions, announced today its partnership with Medidata to support the use of medical imaging in clinical trials. The Medidata ...
... (CDCN) discovered new patient subgroups, based on previously unknown proteomic signatures, with Medidata's Rave Omics, a machine learning-based solution. These discoveries provide novel insights into ...
... the Southern District of New York has rejected Veeva's motion to dismiss Medidata's complaint against Veeva for theft of trade secrets, the company announced today. ...
... adoption of CTMS solutions is anticipated to drive the market growth. Medidata Solutions Inc.; Increasing investment by pharmaceutical and biotechnology companies coupled with government funding ...
... a large-scale proteomics study of idiopathic multicentric Castleman disease (iMCD), supported by Medidata Rave Omics, at the 60th Annual Meeting of the American Society of ...
